Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Financials
experimental
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
FutureFuel Corp.
SIC 2860 · Industrial Organic Chemicals
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Financials
experimental
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
FutureFuel Corp.
SIC 2860 · Industrial Organic Chemicals
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Financials
experimental
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
FutureFuel Corp.
SIC 2860 · Industrial Organic Chemicals
Support
about
terms
$
FF
FutureFuel Corp.
CIK:
0001337298
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
Consolidated Statements of Operations and Net Income (Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue
$ 78,726
$ 35,673
$ 110,678
$ 53,211
Cost of goods sold
47,387
79,572
Gross profit (loss)
15,023
(12,393)
(835)
(27,581)
Selling, general, and administrative expenses
Compensation expense
1,391
1,191
2,660
3,131
Other expense, net
1,562
868
4,307
1,651
Related party expense
127
169
258
330
Research and development expenses
692
933
1,532
2,324
Total operating expenses
3,772
3,161
8,757
7,436
Income (loss) from operations
11,251
(15,554)
(9,592)
(35,017)
Interest income
209
1,068
507
2,305
Interest expense
(30)
(26)
(59)
(62)
Other income
9
505
9
505
Other income, net
188
1,547
457
2,748
Income (loss) before taxes
11,439
(14,007)
(9,135)
(32,269)
Income tax provision
69
183
77
15
Net income (loss)
$ 11,370
$ (14,190)
$ (9,212)
$ (32,284)
Earnings (loss) per common share
Basic (in dollars per share)
$ 0.25
$ (0.32)
$ (0.21)
$ (0.74)
Diluted (in dollars per share)
$ 0.25
$ (0.32)
$ (0.21)
$ (0.74)
Weighted average shares outstanding
Basic (in shares)
44,029,003
43,803,243
44,027,914
43,803,243
Diluted (in shares)
44,039,829
43,803,243
44,027,914
43,803,243
Non-related Parties [Member]
Revenue
$ 78,726
$ 35,673
$ 110,627
$ 53,211
Non-related Parties [Member] | Excluding Shipping and Handling [Member]
Cost of goods sold
62,620
47,387
109,632
79,572
Non-related Parties [Member] | Shipping and Handling [Member]
Cost of goods sold
1,080
641
1,878
1,131
Related Parties [Member]
Revenue
0
0
51
Related Parties [Member] | Excluding Shipping and Handling [Member]
Cost of goods sold
3
1
3
3
Related Parties [Member] | Shipping and Handling [Member]
Cost of goods sold
$ 0
$ 37
$ 0
$ 86
v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities
Net loss
$ (9,212)
$ (32,284)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
5,331
4,739
Amortization of deferred financing costs
38
44
Provision for deferred income taxes
63
2
Change in fair value of derivative instruments
(735)
(281)
Stock based compensation
529
462
Gain on disposal of property and equipment
0
(34)
Change in allowance for credit losses
9
15
Change in inventory reserve
501
524
Noncash interest expense
18
18
Changes in operating assets and liabilities:
Accounts receivable
(10,708)
10,935
Inventory
(11,859)
14,750
Income tax receivable
11
3
Other assets
(4,639)
(2,941)
Dividends payable
16
0
Accrued expenses and other current liabilities
1,150
3,579
Deferred revenue
(524)
3,142
Other noncurrent liabilities
12,707
(2,263)
Net cash used in operating activities
(1,227)
(183)
Cash flows from investing activities
Collateralization of derivative instruments
726
859
Proceeds from the sale of property and equipment
0
34
Capital expenditures
(13,378)
(9,478)
Net cash used in investing activities
(12,652)
(8,585)
Cash flows from financing activities
Payment of dividends
(3,071)
(5,256)
Deferred financing costs
0
(365)
Net cash used in financing activities
(3,071)
(5,621)
Cash paid for income taxes
3
10
Net change in cash and cash equivalents
(16,950)
(14,389)
Cash and cash equivalents at beginning of period
51,316
109,541
Cash and cash equivalents at end of period
34,366
95,152
Noncash investing and financing activities
ROU assets obtained in exchange for new operating lease liabilities
324
0
Change in noncash capital expenditures
(1,382)
1,333
Nonrelated Party [Member]
Changes in operating assets and liabilities:
Prepaid expenses
1,976
1,882
Accounts payable
14,100
(2,367)
Related Party [Member]
Changes in operating assets and liabilities:
Prepaid expenses
0
(12)
Accounts payable
$ 1
$ (96)
v3.26.1
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Assets
Cash and cash equivalents
$ 34,366
$ 51,316
Accounts receivable, net of allowances for expected credit losses of $36 and $28, respectively
20,104
9,405
Inventory, net
40,692
29,334
Income tax receivable
77
88
Prepaid expenses
2,101
4,077
Other current assets
18,930
14,383
Total current assets
116,270
108,603
Property, plant and equipment, net
93,462
86,797
Other assets
5,309
4,922
Total noncurrent assets
98,771
91,719
Total Assets
215,041
200,322
Liabilities and Stockholders’ Equity
Deferred revenue – current
661
1,519
Dividends payable
574
2,761
Accrued expenses and other current liabilities
3,994
2,783
Total current liabilities
28,621
17,736
Deferred revenue – noncurrent
11,978
11,644
Dividends payable - noncurrent
206
196
Noncurrent deferred income taxes
1,118
1,055
Other noncurrent liabilities
20,036
7,048
Total noncurrent liabilities
33,338
19,943
Total liabilities
61,959
37,679
Commitments and contingencies
Preferred stock, $0.0001 par value, 5,000,000 shares authorized, none issued and outstanding
0
0
Common stock, $0.0001 par value, 75,000,000 shares authorized, 43,863,318 and 43,863,507 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
4
4
Additional paid in capital
203,438
203,771
Retained earnings (accumulated deficit)
(50,360)
(41,132)
Total stockholders’ equity
153,082
162,643
Total Liabilities and Stockholders’ Equity
215,041
200,322
Nonrelated Party [Member]
Liabilities and Stockholders’ Equity
Accounts payable
23,351
10,633
Related Party [Member]
Liabilities and Stockholders’ Equity
Accounts payable
$ 41
$ 40